Putting Science to Work

In the News

Company on a path of recovery; Q1 has been solid: Manoj Nerurkar, Syngene International

Economic Times-28/07/2017. Clearly we are on a recovery path, we believe we made a significant progress going from minus 6% to plus 6% in terms of revenue growth ...

Discovery Chemistry Discovery Biology Safety Assessment Large Molecule Development Chemical Development Formulation Development Stability Studies Polymer Research Integrated Discovery & Development Clinical Development Services Bioinfomatics Antibody Drug Conjugates Oligonucleotide Synthesis Contact Us

This site is best viewed in Firefox (29+), Chrome (35+), or Microsoft Internet Explorer (9+)

Social Widget